Suchergebnisse - "cytokine release syndrome"

PubPharm (1.396)

81

COVID-19-related posterior reversible encephalopathy syndrome : insights from a clinical case

enthalten in: Encephalitis (Seoul, Korea) | 2024

von Dehdab, R. | Afat, S.

82

Biomarkers for prediction of CAR T therapy outcomes : current and future perspectives

enthalten in: Frontiers in immunology | 2024

von Levstek, L. | Janžič, L. | Ihan, A. | +1

83

Nurses' roles in CAR-T therapy for B-cell malignancies and managing associated cytokine release syndrome

enthalten in: Asia-Pacific journal of oncology nursing | 2024

von Nwozichi, C. | Ogunmuyiwa, A. | Ojewale, M.

84

Significance of alkaline Phosphatase After Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Dong, R. | Wang, Y. | Sun, X. | +8

85

Advancements in Cell-Based Therapies for HIV Cure

enthalten in: Cells | 2023

von Matsui, Y. | Miura, Y.

86

Toxicities of CAR T-cell therapy : a review of current literature

enthalten in: Annals of medicine and surgery (2012) | 2023

von Asghar, M. | Ismail Shah, S. | Rani, A. | +11

87

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy : A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to Chimeric Antigen Receptor T-Cell Therapy (CAR-T) in Hematological Malignancies

enthalten in: ClinicalTrials.gov | 2023

88

Evolving CAR-T-Cell Therapy for Cancer Treatment : From Scientific Discovery to Cures

enthalten in: Cancers | 2023

von Majumder, A.

89

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation : A Single-Arm, Open-Label, Pilot Study and Expansion Study of JAK Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

enthalten in: ClinicalTrials.gov | 2023

90

End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations

enthalten in: International journal of pharmaceutics: X | 2023

von Larivière, L. | Krüger, J. | von Hirschheydt, T. | +4